Will your health plan cover new obesity drugs?
A patient with a Wegovy pen in her home in Burlington, North Carolina on Monday, March 27, 2023.
Photographer: Rachel Jessen/BloombergHi, it’s Bob in New York. Costly new obesity drugs called GLP-1 receptor agonists could dramatically change weight-loss treatment — but only if insurers are willing to pay for them. But first...
Drugs such as Wegovy, Ozempic and Mounjaro have become a social media phenomenon thanks to the dramatic weight loss they are able to produce. All three are used for shedding pounds, even though only Novo Nordisk’s Wegovy is formally approved for obesity.